Home › Funds › Vivo Capital, LLC › ORIC

Vivo Capital, LLC position in ORIC

ORIC PHARMACEUTICALS INC · Health Care

Vivo Capital, LLC reported holding 924,392 shares of ORIC (ORIC PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$12.5M, representing 1.41% of its reported portfolio and ranking #24 among its reported holdings. Vivo Capital, LLC has disclosed ORIC holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)924.39K sh
Reported value held$12.45M
Portfolio Weight1.41%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Vivo Capital, LLC's ORIC position evolved

Vivo Capital, LLC first disclosed a stake in ORIC in Q3 2023 at 777,944 shares (US$4.7M). The position peaked in Q3 2025 at 3,126,604 shares, worth US$37.5M. Across 13 filings, Vivo Capital, LLC increased the stake 5 time(s), trimmed it 3 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 924,392 shares valued at US$12.5M — a reduction of -924,394 shares quarter over quarter.. Notable position changes include a 63% increase in Q1 2025 (shares rose 82% over the following quarter), a 50% increase in Q2 2025 (shares rose 18% over the following quarter), a 50% trim in Q3 2026 (shares fell 42% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 777.94K $4.71M New
Q4 2023 849.68K $7.82M Add
Q1 2024 849.68K $11.68M Hold
Q2 2024 1.27M $8.98M Add
Q3 2024 1.28M $13.10M Add
Q4 2024 1.28M $10.31M Hold
Q1 2025 2.08M $11.61M Add
Q2 2025 3.13M $31.74M Add
Q3 2025 3.13M $37.52M Hold
Q4 2025 2.12M $17.33M Reduce
Q1 2026 1.85M $23.42M Reduce
Q2 2026 1.85M $20.02M Hold
Q3 2026 924.39K $12.45M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ORIC and 13F data

ORIC (ORIC PHARMACEUTICALS INC) is a Health Care company. 40 other funds we track also report a position in ORIC — the largest reported positions include Nextech Invest Ltd. (US$77.6M), EcoR1 Capital, LLC (US$72.9M), SR ONE CAPITAL MANAGEMENT, LP (US$50.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ORIC

All ORIC fund holders →

FAQ

How long has Vivo Capital, LLC held ORIC?

Vivo Capital, LLC has disclosed ORIC holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Vivo Capital, LLC's current position in ORIC?

As of Q3 2026, Vivo Capital, LLC holds 924.39K shares of ORIC (ORIC PHARMACEUTICALS INC), valued at $12.45M, representing 1.41% of its reported portfolio and ranking #24.

Has Vivo Capital, LLC been buying or selling ORIC?

In the latest 13F filing (Q3 2026), Vivo Capital, LLC reduced its position in ORIC. The position peaked in Q3 2025 at 3.13M shares.

Which other funds hold ORIC?

Other major institutional holders of ORIC include Nextech Invest Ltd., EcoR1 Capital, LLC, SR ONE CAPITAL MANAGEMENT, LP, among 40 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.